Published in PLoS One on December 16, 2011
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol (2014) 1.79
Novel allelic variants and evidence for a prevalent mutation in URAT1 causing renal hypouricemia: biochemical, genetics and functional analysis. Eur J Hum Genet (2013) 0.95
High frequency of SLC22A12 variants causing renal hypouricemia 1 in the Czech and Slovak Roma population; simple and rapid detection method by allele-specific polymerase chain reaction. Urolithiasis (2015) 0.81
Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2. Clin Exp Nephrol (2015) 0.77
Transcriptome-based reconstructions from the murine knockout suggest involvement of the urate transporter, URAT1 (slc22a12), in novel metabolic pathways. Biochem Biophys Rep (2015) 0.75
Total saponins from Discorea nipponica makino ameliorate urate excretion in hyperuricemic rats. Pharmacogn Mag (2015) 0.75
Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy. World J Diabetes (2015) 0.75
Characterisation of risk factors for stones in hyperuricosuric men attending a stone clinic. Urolithiasis (2014) 0.75
Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet (2008) 7.33
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet (2008) 5.93
Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature (2002) 5.62
The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet (2007) 3.21
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet (2008) 2.21
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem (2008) 2.09
New insights into renal transport of urate. Curr Opin Rheumatol (2007) 2.07
Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol (2004) 1.87
Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol (2009) 1.52
The case: a young man with acute kidney injury after exercise. The diagnosis: exercise induced acute kidney injury in hereditary renal hypouricemia. Kidney Int (2010) 1.42
Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest (2001) 1.40
The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J Biol Chem (2004) 1.40
Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients. Am J Hypertens (2008) 1.15
Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum Mol Genet (2011) 1.13
Exercise-induced acute renal failure associated with renal hypouricaemia: results of a questionnaire-based survey in Japan. Nephrol Dial Transplant (2004) 1.10
Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem (2010) 1.09
A 'complexity' of urate transporters. Kidney Int (2010) 1.06
Atypical presentation of distal renal tubular acidosis in two siblings. Pediatr Nephrol (2008) 1.04
Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance. J Clin Endocrinol Metab (2004) 1.03
Mutational analysis of idiopathic renal hypouricemia in Korea. Pediatr Nephrol (2005) 1.02
Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) (2006) 1.02
Proximal renal tubular dysfunction in primary distal renal tubular acidosis. Pediatr Nephrol (2004) 0.98
Cause of persistent hypouricemia in outpatients. Nephron (1989) 0.98
Acute renal failure due to uric acid nephropathy in a patient with renal hypouricemia. Klin Wochenschr (1989) 0.97
Two male siblings with hereditary renal hypouricemia and exercise-induced ARF. Am J Kidney Dis (2003) 0.97
Hereditary renal hypouricemia. Mol Genet Metab (2006) 0.94
Recurrent URAT1 gene mutations and prevalence of renal hypouricemia in Japanese. Pediatr Nephrol (2005) 0.92
Oxidative imbalance in idiopathic renal hypouricemia. Pediatr Nephrol (2008) 0.91
Concentration-dependent inhibitory effect of irbesartan on renal uric acid transporters. J Pharmacol Sci (2010) 0.90
The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia. Pediatr Nephrol (2004) 0.90
URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews. Nephrol Dial Transplant (2010) 0.87
Prevalence of hypouricaemia and SLC22A12 mutations in healthy Korean subjects. Nephrology (Carlton) (2008) 0.87
Renal handling of uric acid in patients with type 1 diabetes in relation to glycemic control. Arch Med Res (2005) 0.83
Renal hypouricemia in school-aged children: screening of serum uric acid level before physical training. Pediatr Nephrol (2006) 0.83
A case of exercise-induced acute renal failure in a patient with idiopathic renal hypouricemia developed during antihypertensive therapy with losartan and trichlormethiazide. Hypertens Res (2003) 0.82
Exercise-induced acute renal failure in a patient with renal hypouricemia. Pediatr Nephrol (2000) 0.82
Hypouricemia in individuals admitted to an inpatient hospital-based facility. Am J Kidney Dis (2003) 0.81
Analysis of mutations in the urate transporter 1 (URAT1) gene of Japanese patients with hypouricemia in northern Japan and review of the literature. Ren Fail (2006) 0.81
Functional analysis of human organic cation transporter OCT3 (SLC22A3) polymorphisms. J Pharmacol Sci (2010) 0.81
Absence of SLC22A12 gene mutations in Greek Caucasian patients with primary renal hypouricaemia. Scand J Clin Lab Invest (2007) 0.80
Non-urate transporter 1-related renal hypouricemia and acute renal failure in an Israeli-Arab family. Pediatr Nephrol (2009) 0.79
Renal hypouricemia is an ominous sign in patients with severe acute respiratory syndrome. Am J Kidney Dis (2005) 0.79
Hypouricemia in severely disabled children: influence of valproic acid and bed-ridden state. Brain Dev (2003) 0.78
[Hereditary renal hypouricemia in a Caucasian patient: a case report and review of the literature]. Nephrol Ther (2009) 0.78
The effect of trimethoprim on potassium and uric acid metabolism in normal human subjects. Clin Nephrol (2001) 0.77
[Vesical uric acid lithiasis in a child with renal hypouricemia]. An Esp Pediatr (2001) 0.77
A case of exercise-induced acute renal failure in a patient with enhanced renal hypouricaemia. Nephrol Dial Transplant (2000) 0.77
Acute renal failure after exercise in a Japanese sumo wrestler with renal hypouricemia. Am J Med Sci (2008) 0.76
Exercise-induced acute renal failure in a patient with congenital renal hypouricaemia. Nephrol Dial Transplant (1998) 0.76
Hypouricemia in a patient with thyrotoxicosis. Eur J Endocrinol (2001) 0.76
Pseudoaldosteronism with increased serum cortisol associated with pneumonia, hypouricemia, hypocalcemia, and hypophosphatemia. Clin Nephrol (2010) 0.76
Familial hypouricaemia associated with renal tubular uricosuria and uric acid calculi: case report. J Clin Pathol (1980) 0.76
SLC22A12 W258X frequency according to serum uric acid level among Japanese health checkup examinees. Nagoya J Med Sci (2011) 0.76
A case of renal hypouricemia caused by urate transporter 1 gene mutations. Clin Nephrol (2006) 0.76
Hyperuricosuria in the Fanconi syndrome. Am J Med Sci (1977) 0.75
Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature (2002) 5.62
In-frame deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse. Hum Mol Genet (2006) 3.90
Nephrocystin-5, a ciliary IQ domain protein, is mutated in Senior-Loken syndrome and interacts with RPGR and calmodulin. Nat Genet (2005) 3.55
Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell (2012) 2.54
Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. Nat Genet (2007) 2.46
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem (2008) 2.09
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat Genet (2012) 1.74
Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum. Hum Mutat (2010) 1.67
Copy-number disorders are a common cause of congenital kidney malformations. Am J Hum Genet (2012) 1.63
Mutation analysis of NPHP6/CEP290 in patients with Joubert syndrome and Senior-Løken syndrome. J Med Genet (2007) 1.56
DNA replication stress underlies renal phenotypes in CEP290-associated Joubert syndrome. J Clin Invest (2015) 1.55
Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol (2010) 1.53
Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension. Hypertension (2013) 1.52
Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci (2004) 1.52
A nationwide study of mass urine screening tests on Korean school children and implications for chronic kidney disease management. Clin Exp Nephrol (2012) 1.50
Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet (2004) 1.45
Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem (2003) 1.34
Regulation of prostasin by aldosterone in the kidney. J Clin Invest (2002) 1.33
Nephronophthisis. Eur J Hum Genet (2008) 1.27
Genetic and physical interaction between the NPHP5 and NPHP6 gene products. Hum Mol Genet (2008) 1.26
Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther (2003) 1.25
Jouberin localizes to collecting ducts and interacts with nephrocystin-1. Kidney Int (2008) 1.24
High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions. Pathol Int (2011) 1.22
Identification of the first AHI1 gene mutations in nephronophthisis-associated Joubert syndrome. Pediatr Nephrol (2005) 1.22
Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A (2014) 1.20
Individuals with mutations in XPNPEP3, which encodes a mitochondrial protein, develop a nephronophthisis-like nephropathy. J Clin Invest (2010) 1.20
Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann Rheum Dis (2009) 1.16
Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. Hum Mutat (2012) 1.15
L-type amino acid transporter 1 inhibitors inhibit tumor cell growth. Cancer Sci (2009) 1.13
A meckelin-filamin A interaction mediates ciliogenesis. Hum Mol Genet (2011) 1.12
Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. Biochim Biophys Acta (2002) 1.10
Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expression. Hum Mol Genet (2010) 1.10
Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatology (2007) 1.09
Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem (2010) 1.09
Primary focal segmental glomerular sclerosis in children: clinical course and prognosis. Pediatr Nephrol (2006) 1.09
Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions. Biochem Biophys Res Commun (2004) 1.09
Renal manifestations of Dent disease and Lowe syndrome. Pediatr Nephrol (2007) 1.09
Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr (2009) 1.09
LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells. J Immunol (2013) 1.07
Unilateral renal angiodysplasia in a girl with hypertension. Pediatr Nephrol (2005) 1.06
Idiopathic membranous nephropathy in children. Pediatr Nephrol (2006) 1.05
Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate. Pediatr Nephrol (2007) 1.05
Central precocious puberty that appears to be sporadic caused by paternally inherited mutations in the imprinted gene makorin ring finger 3. J Clin Endocrinol Metab (2014) 1.05
Atypical presentation of distal renal tubular acidosis in two siblings. Pediatr Nephrol (2008) 1.04
Variable phenotype of Pierson syndrome. Pediatr Nephrol (2008) 1.04
Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. J Am Soc Nephrol (2005) 1.03
Aberrant ENaC activation in Dahl salt-sensitive rats. J Hypertens (2009) 1.03
Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter. J Biol Chem (2010) 1.03
Functional characterization of rat organic anion transporter 5 (Slc22a19) at the apical membrane of renal proximal tubules. J Pharmacol Exp Ther (2005) 1.02
A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. Am J Physiol Renal Physiol (2012) 1.02
Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency. Pediatr Res (2009) 1.02
Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium. Am J Kidney Dis (2006) 1.02
Altered expression of rat renal cortical OAT1 and OAT3 in response to bilateral ureteral obstruction. Kidney Int (2005) 1.01
Familial focal segmental glomerulosclerosis associated with an ACTN4 mutation and paternal germline mosaicism. Am J Kidney Dis (2008) 1.00
Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther (2002) 0.99
Sodium-hydrogen exchanger regulatory factor-1 interacts with mouse urate transporter 1 to regulate renal proximal tubule uric acid transport. J Am Soc Nephrol (2007) 0.98
Liddle's syndrome caused by a novel mutation in the proline-rich PY motif of the epithelial sodium channel beta-subunit. J Clin Endocrinol Metab (2004) 0.98
Genetic basis of Bartter syndrome in Korea. Nephrol Dial Transplant (2011) 0.98
Decreased renal uptake of (99m)Tc-DMSA in patients with tubular proteinuria. Pediatr Nephrol (2009) 0.98
Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies. Clin Exp Nephrol (2011) 0.98
Clinical outcomes of childhood lupus nephritis: a single center's experience. Pediatr Nephrol (2006) 0.98
Two male siblings with hereditary renal hypouricemia and exercise-induced ARF. Am J Kidney Dis (2003) 0.97
Clinical features of A3243G mitochondrial tRNA mutation. Brain Dev (2004) 0.97
Nephronophthisis: a genetically diverse ciliopathy. Int J Nephrol (2011) 0.97
Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia. J Clin Endocrinol Metab (2005) 0.97
Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem (2002) 0.97
CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products. Am J Physiol Renal Physiol (2008) 0.97
Association between GLUT9 and gout in Japanese men. Ann Rheum Dis (2010) 0.96
Nutcracker syndrome in children with gross haematuria: Doppler sonographic evaluation of the left renal vein. Pediatr Radiol (2006) 0.96
Familial renal glucosuria: a clinicogenetic study of 23 additional cases. Pediatr Nephrol (2012) 0.95
Naturally occurring antisense RNA: function and mechanisms of action. Curr Opin Nephrol Hypertens (2009) 0.95
Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension. J Hypertens (2009) 0.95
Integrated physiology of proximal tubular organic anion transport. Curr Opin Nephrol Hypertens (2005) 0.95
Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule. J Biol Chem (2003) 0.94
Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. Eur J Pharmacol (2003) 0.94
In vivo contribution of serine proteases to the proteolytic activation of γENaC in aldosterone-infused rats. Am J Physiol Renal Physiol (2012) 0.94
WT1 and NPHS2 mutations in Korean children with steroid-resistant nephrotic syndrome. Pediatr Nephrol (2007) 0.93
Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid. Basic Clin Pharmacol Toxicol (2008) 0.93
The impact of CFNS-causing EFNB1 mutations on ephrin-B1 function. BMC Med Genet (2010) 0.93
Establishment and characterization of mammalian cell lines stably expressing human L-type amino acid transporters. J Pharmacol Sci (2008) 0.93
Elimination of organic anions in response to an early stage of renal ischemia-reperfusion in the rat: role of basolateral plasma membrane transporters and cortical renal blood flow. Pharmacology (2007) 0.93
Renal manifestations of patients with MYH9-related disorders. Pediatr Nephrol (2011) 0.93
Interactions of urate transporter URAT1 in human kidney with uricosuric drugs. Nephrology (Carlton) (2011) 0.93
Long-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics. Eur J Endocrinol (2011) 0.93
Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome. Pediatr Nephrol (2011) 0.93
Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones. Am J Physiol Renal Physiol (2006) 0.92
Acute leukemia: an association with atypical hemolytic uremic syndrome. Pediatr Nephrol (2003) 0.92